Martinez-Martin, Pablo http://orcid.org/0000-0003-0837-5280
Skorvanek, Matej http://orcid.org/0000-0001-5497-8715
Henriksen, Tove http://orcid.org/0000-0002-5171-1166
Lindvall, Susanna
Domingos, Josefa http://orcid.org/0000-0001-9390-6183
Alobaidi, Ali http://orcid.org/0000-0002-0720-7894
Kandukuri, Prasanna L. http://orcid.org/0000-0002-3702-4343
Chaudhari, Vivek S. http://orcid.org/0000-0002-5286-9213
Patel, Apeksha B. http://orcid.org/0000-0002-8948-6785
Parra, Juan Carlos http://orcid.org/0000-0002-5613-6121
Pike, James http://orcid.org/0000-0002-4208-2871
Antonini, Angelo http://orcid.org/0000-0003-1040-2807
Funding for this research was provided by:
AbbVie
Article History
Received: 18 May 2022
Revised: 25 November 2022
Accepted: 22 December 2022
First Online: 12 January 2023
Declarations
:
: PMM has received honoraria from National School of Public Health (ISCIII), and Editorial Viguera for lecturing in courses; from Bial for advice in a clinical-epidemiological study; and from the International Parkinson and Movement Disorder Society (IPMDS) for management of the Program on Rating Scales. He received grant support from International Parkinson and Movement Disorder Society, for development and validation of the MDS-NMS. MS received speakers’ honoraria and/or consultation fees from AbbVie, Biogen, Boston Scientific, Ever Pharma, Krka, Medtronic and Sandoz, he received grant support from the IBM, from Slovak grant agencies under contracts APVV-18-0547 and VEGA 1/0596/19 and the Operational Program Integrated Infrastructure, funded by the ERDF under No. ITMS2014 + :313011V455. TH has received honorary for speaker related activities for Lundbeck, Lobsor, Zambon, Britannia, EVER Pharma, and AbbVie. AA has received compensation for consultancy and speaker related activities from UCB, Boehringer–Ingelheim, Britannia, AbbVie, Kyowa Kirin, Zambon, Bial, Neuroderm, Theravance Biopharma, Roche; he receives research support from Chiesi Pharmaceuticals, Lundbeck, Horizon 2020—Grant 825785, Horizon2020 Grant 101016902, Ministry of Education University and Research (MIUR) Grant ARS01_01081, Cariparo Foundation. He serves as consultant for Boehringer–Ingelheim for legal cases on pathological gambling. AA, PLK, ABP, and JCP are employees of AbbVie and may own stocks/shares in the company. VSC is a former employee of AbbVie Inc., currently employed by EMD Serono, Inc. and may hold AbbVie stock. JP is an employee of Adelphi Real World, a consulting company that was hired by AbbVie to perform analyses on the Adelphi Disease Specific Program database. SL and JD declare that they have no relevant or material financial interests that relate to the research described in this paper.
: Respondents provided informed consent for use of their data; all data were aggregated and de-identified before receipt. Surveys were conducted in full accordance with the US Health Insurance Portability and Accountability Act of 1996. The study protocol was approved by the Western Institutional Review Board (Puyallup, Washington, US) on 3 July 2019. All data were collected according to the requirements of ethics committee approval, including obtaining participants’ informed consent.
: Consent to publish was provided by all authors.